TCL Archive ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer. March 24, 2006
TCL Archive NCI To Appoint Expert Group To Consider Standards For Outcomes Measurement. September 29, 2000